205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
75.78%
Net income growth above 1.5x AVGO's 8.21%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
No Data
No Data available this quarter, please select a different quarter.
466.67%
Well above AVGO's 300.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-221.88%
Negative yoy SBC while AVGO is 15.38%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
110.78%
Slight usage while AVGO is negative at -420.83%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
111.92%
AR growth while AVGO is negative at -264.71%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
215.63%
Inventory growth well above AVGO's 108.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
3.85%
A yoy AP increase while AVGO is negative at -228.57%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
17.28%
Lower 'other working capital' growth vs. AVGO's 166.67%. David Dodd would see fewer unexpected short-term demands on cash.
-48.98%
Both negative yoy, with AVGO at -102.24%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
78.07%
Some CFO growth while AVGO is negative at -39.34%. John Neff would note a short-term liquidity lead over the competitor.
-2.74%
Both yoy lines negative, with AVGO at -16.07%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-257.59%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-78.12%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-548.91%
Both yoy lines negative, with AVGO at -19.64%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
13.04%
Debt repayment growth of 13.04% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-7.35%
Both yoy lines negative, with AVGO at -64.71%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-100.00%
Both yoy lines negative, with AVGO at -150.00%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.